A number of firms have modified their ratings and price targets on shares of DigitalOcean (NYSE: DOCN) recently: 11/5/2026 – DigitalOcean had its price target lowered by The Goldman Sachs Group from $178.00 to $156.00. They now have a “buy” rating on the stock. 11/4/2026 – DigitalOcean was downgraded by Weiss Ratings from “hold (c+)” […]

Shift4 Payments (NYSE: FOUR) has recently received a number of price target changes and ratings updates: 11/10/2026 – Shift4 Payments had its price target raised by Mizuho from $46.00 to $56.00. They now have an “outperform” rating on the stock. 11/6/2026 – Shift4 Payments had its “neutral” rating reaffirmed by Bank of America. 11/6/2026 – […]

e.l.f. Beauty (NYSE: ELF) recently received a number of ratings updates from brokerages and research firms: 11/10/2026 – e.l.f. Beauty had its price target raised by Morgan Stanley from $103.00 to $125.00. They now have an “equal weight” rating on the stock. 11/8/2026 – e.l.f. Beauty was downgraded by Wall Street Zen from “buy” to […]

A number of research firms have changed their ratings and price targets for ACADIA Pharmaceuticals (NASDAQ: ACAD): 11/6/2026 – ACADIA Pharmaceuticals had its price target raised by Canaccord Genuity Group from $36.00 to $38.00. They now have a “buy” rating on the stock. 11/5/2026 – ACADIA Pharmaceuticals had its price target raised by Royal Bank […]

Several analysts have recently updated their ratings and price targets for Rogers (NYSE: ROG): 11/9/2026 – Rogers had its price target lowered by B. Riley Financial from $195.00 to $180.00. They now have a “buy” rating on the stock. 10/31/2026 – Rogers was upgraded by Wall Street Zen from “hold” to “buy”. 10/28/2026 – Rogers […]

Several brokerages have updated their recommendations and price targets on shares of Collegium Pharmaceutical (NASDAQ: COLL) in the last few weeks: 11/7/2026 – Collegium Pharmaceutical was upgraded by Wall Street Zen from “hold” to “buy”. 11/6/2026 – Collegium Pharmaceutical had its “buy” rating reaffirmed by Jefferies Financial Group. They now have a $35.00 price target […]